Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MS/Jackson
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Jackson, MS

Studies commonly pay $75 to $4,500 per completed study

227 clinical trials are currently recruiting participants within 30 miles of Jackson. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

227studies recruiting
9+research centers nearby
7condition categories
Live from the NIH registry

Studies recruiting near Jackson right now

Top 25 of 227 recruiting studies, sorted by proximity — each links to its official registry page

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University Telemedicine — Jackson, Mississippi (2.0 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
University of Mississippi Medical Center ( Site 0043) — Jackson, Mississippi (2.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Epithelial Ovarian Cancer, Fallopian Tube Cancer Phase 2 Interventional 140 participants sought
University Of Mississippi Medical Center /ID# 276342 — Jackson, Mississippi (2.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06890338)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Jackson, Mississippi (2.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

Geographic Atrophy Secondary to Age-related Macular Degeneration Phase 2 Interventional 240 participants sought
Mississippi Retina Associates — Madison, Mississippi (11.6 mi) · Sponsor: Apellis Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07215390)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Malignant Glioma Phase 1, Phase 2 Interventional 132 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05099003)

Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt

Right-To-Left Shunt Phase 3 Interventional 300 participants sought
Jackson Heart Clinic — Jackson, Mississippi (2.0 mi) · Sponsor: Agitated Solutions, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06938347)

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Obesity, Overweight Phase 3 Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Ridgeland, Mississippi (9.1 mi) · Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07654374)

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease N/A Observational 3,000 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT01915511)

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome N/A Observational 330 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05702645)

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Bipolar Disorder Type I With Mania or Mania With Mixed Features Phase 3 Interventional 274 participants sought
Precise Research Centers — Flowood, Mississippi (4.3 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT06951711)

Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors

Solid Tumor Phase 1 Interventional 200 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: Oxford BioTherapeutics Ltd
See eligibility & contact on ClinicalTrials.gov (NCT04064359)

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Pancreatic Cancer N/A Observational 125 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT05687188)

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Obesity & Overweight, Mobility Disability Phase 2 Interventional 200 participants sought
SKY Integrative Medical Center — Ridgeland, Mississippi (9.1 mi) · Sponsor: Veru Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07446998)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT04322318)

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Endometrial Cancer, Cervical Cancer N/A Observational 3,110 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: Mayo Clinic
See eligibility & contact on ClinicalTrials.gov (NCT05051722)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Phase 3 Interventional 1,350 participants sought
89bio Clinical Study Site — Flowood, Mississippi (4.3 mi) · Sponsor: 89bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06318169)

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 425 participants sought
Gastrointestinal Associates Research — Flowood, Mississippi (4.3 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06819891)

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hematologic Malignancies, Inherited Disorders of Metabolism N/A Observational 99,999 participants sought
Univeristy of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: Center for International Blood and Marrow Transplant Research
See eligibility & contact on ClinicalTrials.gov (NCT01351545)

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Cardiotoxicity, HER2/Neu Positive Phase 3 Interventional 491 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03418961)
Actively enrolling

Studies you may be able to join near Jackson

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Jackson

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Umc Clinical Research Program

University Of Mississippi Medical Center - Parking Garage A, 2500 N State St Public Parking A, Jackson, MS 39216
(601) 815-1328

Translational Research Center

★ 5.0
Unnamed Road, Jackson, MS 39216

Research Mississippi

1500 E Woodrow Wilson Ave, Jackson, MS 39216
(601) 364-1315

UMMC Guyton Research Building

★ 5.0
2500 N State St, Jackson, MS 39216
(601) 815-5000

UMMC Cancer Center and Research Institute clinics

★ 4.0 (20 reviews)
inside UMMC, Medical Pavilion, 2500 N State St, Jackson, MS 39216
(601) 815-6700
"The absolute worst place to have to go for treatment. They dont care about you or your time. I get a chemo injection that literally takes 3 mins to g…"
— Heather McDuff, 1★

Precise Research Centers

★ 2.9 (14 reviews)
3531 Lakeland Dr Ste 1060, Flowood, MS 39232
(601) 420-5812
"This place offers no hope of recovery. My requests stay u responded to, the desk agent has no clue what they offer, and the doctors are lazy."
— Amanda Dent, 1★

Jackson Heart Study

350 W Woodrow Wilson Ave Ste 701, Jackson, MS 39213
(601) 815-5791

The ACT Center for Tobacco Treatment, Education, and Research

350 W Woodrow Wilson Ave, Jackson, MS 39213
(601) 815-1180

Rowland Medical Library

★ 5.0
2500 N State St, Jackson, MS 39216
(601) 984-1000
"Nice calm library for staff and students. No public access"
— Ankur Kataria, 5★

Clinical trials in Jackson: what's recruiting

The Jackson area currently has 227 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Jackson, the most active research areas are:

  • Cancer & Oncology15 studies
  • Diabetes & Metabolism3 studies
  • Liver & Kidney2 studies
  • Lungs & Breathing1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Jackson, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Jackson

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Jackson participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Jackson?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Jackson, MS?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Jackson?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Jackson typically complete one or two studies per year.

Paid clinical trials near Jackson

Other metros within reach

Baton Rouge, LA224 Gulfport, MS36 New Orleans, LA556 Metairie, LA527 Mobile, AL173 Lafayette, LA58 Memphis, TN580 Tuscaloosa, AL25

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Jackson Bladder Issues Due To Spinal Cord Injury in Jackson All conditions

More of MS

Gulfport36

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts